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The field of liver transplantation remains one of the last
bastions of paternalism in medicine. Whether constrained
by geography or insurance contracts, most patients have
little choice about which transplant program they visit. To
get on the transplant list, they must undergo a long list of
tests, a list that is unpublicized and keeps changing based
on results of initial testing. During this process their com-
pliance is constantly scrutinized. After jumping through all
these ‘‘hoops,’’ their fate is determined by a committee of
medical professionals who meet privately behind closed
doors.1 Those fortunate enough to overcome these hur-
dles are then ‘‘on call 24/7’’ for organ offers, often being
called in for a possible transplant and then sent home with
little explanation. This disempowering experience is further
exacerbated by constant harassment from the insurance
company with denials of payment for tests that are man-
datory to receive a lifesaving transplant. Then, after every
shred of initiative and autonomy has been stripped away,
patients who undergo transplantation are expected to




The earlier hyperbole is intended to make a point. Liver
transplantation is far from the only service line that occa-
sionally fails to treat the patient as a person. And there are
very good reasons for the system just described. Patients
being considered for liver transplantation often suffer
from progressive debilitation and encephalopathy that
compromise their ability to care for themselves. Further-
more, some patients have a long history of substance
abuse that raises concerns about them serving as good
stewards of a precious societal resource. Given the scarcity
of organs, some type of selection process is needed. How-
ever, it is critical to avoid conflating ability to care for an
organ with value judgments about social worth. Just
because some of the patients we care for have histories of
substance abuse does not mean we should not strive for
the ideal patient experience. The more educated and
empowered patients become, the more they can serve as
active partners rather than passive consumers in health
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care. In other words, patient-centeredness can improve
outcomes. This causal inference has been demonstrated in
various settings including acute myocardial infarction, pri-
mary care, and kidney transplantation.2-4
PATIENT-CENTERED CARE
In its landmark report ‘‘Crossing the Quality Chasm,’’
the Institute of Medicine defined patient-centered care as
‘‘care that is respectful of and responsive to individual
patient preferences, needs, and values and [ensures] that
patient values guide all clinical decisions.’’5 How can
‘‘patient-centeredness’’ be achieved? Many find this term
to be nebulous and subjective, that is, difficult to define
and measure. Others assume that being patient-centered
means letting the patient make unguided medical deci-
sions (it most certainly does not). Rather than struggling
toward a consensus definition, it may be useful to instead
focus on a related yet more concrete concept: patient
involvement. If patients are heavily involved in their care,
chances are that this care will be patient-centered. Possible
ways to achieve this goal include motivational interview-
ing, prehabilitation, using technology, developing a sense
of community, and program leadership.
Motivational Interviewing
This is a technique originally developed for substance
abuse counseling, which seeks to bring out the patient’s
intrinsic motivation rather than attempting to impose
behavior change externally. Steps in this technique in-
clude: (1) engaging the patient in a discussion of his/her
hopes and fears, (2) focusing on the changes necessary
to achieve these hopes or mitigate fears, (3) evoking the
patients intrinsic motivation to meet goals that they
themselves set, and finally (4) planning for how to
accomplish those goals. A common example would be a
55-year-old man who needs to lose 30 pounds in order
to be eligible for liver transplantation. Rather than simply
telling him, ‘‘You have to do this,’’ the motivational
interviewing approach would use the earlier steps to
guide the patient in setting this goal. Motivational inter-
viewing has been shown to be effective in multiple
randomized controlled trials, and use of this technique
may have longer-lasting benefits by increasing patient
engagement and personal responsibility for health care.6
Prehabilitation
Now that our obese patient has set his own goal of
losing 30 pounds, we need to help him accomplish that
goal. Multiple randomized trials have demonstrated that
structured weight-loss programs are more effective than
simply telling the patient to lose weight, yet the latter is
typically what is done.7 Even patients who do not need
to lose weight would benefit from smoking cessation,
dietary improvements, and increased physical activity.
(We measured physical activity among 40 of our listed
patients using an electronic pedometer, and they aver-
aged only 1,000 steps/day; the average American takes
just more than 5,000 steps/day).8 Furthermore, it can be
very empowering for patients to tell them, ‘‘Here’s what
you can do to improve your chances of getting and sur-
viving a transplant,’’ rather than waiting helplessly.
The concept of prehabilitation has recently proved success-
ful in a variety of surgical settings and could be particularly
valuable for organ transplantation given the prolonged wait-
ing times.9 Therefore, we created and pilot-tested a simple
prehabilitation program at our center. Medical students
enrolled the patients, helped them set goals, and called them
weekly to track their progress. Each patient was given an
activity tracker (Fitbit), a log for tracking their diet and activ-
ity, a daily protein and calorie supplement (Nestle Boost
Breeze Juice Drink or BOOST Glucose Control), and access to
individualized resources as needed, such as smoking cessa-
tion programs or weight-loss counseling. Eight patients were
enrolled and participated in the program for 3 months. All
patients completed the program and were compliant with
requirements of the program, and recorded very high satis-
faction scores about their participation (4.8 on a 5-point Lik-
ert scale). Participants had measurable increases in activity,
with an average increase of daily steps from 6,122 (week 2)
to 8,954 (week 8; P < 0.001), and an increase in average 6-
minute walking distance from 392 to 455 m (P 5 0.05). Two
patients who had weight-loss goals as part of the program
lost 11 and 15 pounds, respectively.
Using Technology
The liver transplant process involves quite a few high-
stakes decisions, including whether to undergo transplan-
tation, which organ to accept, or even when it is necessary
to proceed to the emergency department. Truly engaging
patients in shared decision making is difficult because of
time constraints and challenges in risk communication.
Many patients are functionally innumerate and cannot
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mentally process the difference between a 5% and a 10%
risk. Close monitoring of patients is likewise limited by
resource availability. We all know that patients would have
better outcomes and satisfaction with care if we called
daily to check on them, but few transplant programs can
afford to do that. Here is where technology can help. For
organ acceptance decisions, we have developed a patient
decision aid to help educate patients on risk tradeoffs.10 In
our validation study, use of the decision aid resulted in bet-
ter knowledge scores and increased willingness to accept
marginal organs.11 This may not only increase patient
engagement, but also decrease the risk that a patient will
decline a perfectly usable organ in the middle of the night.
For pretransplant monitoring, we have pilot-tested the use
of automated phone systems to prevent unnecessary hos-
pitalization.12 Others have used technology for posttrans-
plant monitoring: the group at the University of Cincinnati
has developed a telehealth tablet program with daily track-
ing of symptoms and vital signs, medication and testing
reminders, and the ability to videoconference with staff at
the transplant center.13
Developing a Sense of Community
Liver transplantation can be an isolating experience.
Many patients feel stigmatized, even if their liver disease
is unrelated to substance abuse.14 As the illness pro-
gresses, patients are typically unable to participate in the
work and social activities that used to keep them con-
nected to other people. This social isolation can have
negative psychological and biological health consequen-
ces.15 Many programs have patient support groups,
which can help develop a new sense of community with
other patients and the transplant program, thus increas-
ing patient involvement. We have recently begun using
technology to videoconference with patients who cannot
attend in person because of distance or infirmity.
Another way to develop this sense of community would
be a formal peer-mentoring program, which has been
shown to be effective in other disease such as diabe-
tes.16 In our early experience with a peer-mentoring pro-
gram at our centers, patients and caregivers have often
cited their peer mentor as an ‘‘essential’’ or ‘‘critical’’
piece of their successful journey to transplant.
Program Leadership
It occurred to us while writing this review that to be truly
patient-centered, transplant programs should involve pa-
tients in leadership and governance. At a macrolevel this
could take the form of a patient advisory board or patient
presence at strategic retreats. At a microlevel, one or more
patients could be assigned as an advisor to the office man-
ager, to help improve things such as response to phone
calls, things that have a large impact on patient satisfac-
tion but are often invisible to physician leaders. We plan to
try out this idea in our own programs.
SUMMARY
We are in the midst of an information revolution in
health care. Tools such as the Internet, patient portals, and
mobile health devices are in the process of decreasing
information asymmetry between patients and providers.
The trick is to use this technology to increase patient
involvement without eroding the ‘‘mastery, autonomy and
purpose’’ that foster professional satisfaction.17
The inherent complexity of liver transplantation means
that it will take more effort to make care patient-centered
than in other areas of medicine. However, the effort should
pay dividends, not only in patient satisfaction but in better
outcomes, which all transplant programs carefully and nerv-
ously scrutinize. Finally, harnessing the energy of patients
and families is a cost-effective approach for programs to
improve care. The earlier list is far from exhaustive, and we
encourage readers to share their ideas. One forum for this
might be the newly developed ‘‘Public Health/Health Care
Delivery’’ Special Interest Group of the American Associa-
tion for the Study of Liver Disease. We are in the process of
creating a Web site for members to share resources and
best practices for improving patient care.18 Although there
are likely diverse approaches to achieving patient-centered
liver transplantation, it is clear that increasing patient in-
volvement is the critical component.
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